Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-१.४१%
१,०७६.१३
-१५.३८
-१.४१%
१,०९१.५११,०९०.४०१,०९०.४०१,०७३.६९
SIXC
Communications
SIXC
Communications
SIXC
-०.५५%
६०६.७४
-३.३७
-०.५५%
६१०.११६१०.११६१०.२९६०६.१७
SIXE
Energy
SIXE
Energy
SIXE
+०.८८%
१,२४८.८२
+१०.८४
+०.८८%
१,२३७.९८१,२३७.८३१,२५२.४११,२२५.०३
SIXI
Industrials
SIXI
Industrials
SIXI
-१.१७%
१,७२४.३६
-२०.३५
-१.१७%
१,७४४.७११,७४०.९५१,७४७.२९१,७२१.५७
SIXM
Financials
SIXM
Financials
SIXM
-०.७२%
६३५.५९
-४.५९
-०.७२%
६४०.१८६३९.९२६४३.१९६३४.७३
SIXR
Staples
SIXR
Staples
SIXR
-०.७६%
८४३.१५
-६.४३
-०.७६%
८४९.५८८४५.२७८५१.६८८३९.४७
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-०.५५%
२१६.२९
-१.१९
-०.५५%
२१७.४८२१७.४८२१८.१६२१५.५१
SIXT
Technology
SIXT
Technology
SIXT
+०.०८%
३,२६३.४१
+२.७२
+०.०८%
३,२६०.६९३,२७३.३६३,२८७.८१३,२४०.७८
SIXU
Utilities
SIXU
Utilities
SIXU
-०.३४%
९३९.२४
-३.२१
-०.३४%
९४२.४५९३९.३९९४८.८०९३३.९८
SIXV
Health care
SIXV
Health care
SIXV
-०.२९%
१,४६२.५६
-४.२४
-०.२९%
१,४६६.८०१,४६४.७०१,४६७.१९१,४५८.३६
SIXY
Discretionary
SIXY
Discretionary
SIXY
-०.७१%
२,३८०.४०
-१७.१०
-०.७१%
२,३९७.५०२,३९५.०३२,४१२.०१२,३७०.६४
Q1 2026 earnings • in 2 days
See details
ONC:NASDAQ
BeOne Medicines AG
US$ २९७.१४
+१.१२%
(+३.२८) 1D
US$ २९७.१४
०.००% (०.००)
After hours
Closed: मे ४, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ONC...
Open
US$ २९३.८८
High
US$ ३००.७६
Low
US$ २९३.५०
Mkt. cap
३५.५५ अरब
Avg. vol.
२.०४ लाख
Volume
१.३५ लाख
52-wk high
US$ ३८५.२२
52-wk low
US$ २१८.३१
Beta
०.५०
Shares outstanding
११.८६ करोड
No. of employees
१२ हजार
News stories
From sources across the web
TipRanks
TipRanks
·
१ घण्टा पहिले
Why Is SPDR S&P 500 ETF Trust (SPY) Down Today, 5/4/2026?
Stock Titan
Stock Titan
·
१ घण्टा पहिले
Cambium catches up on SEC reports as Nasdaq delisting appeal continues
Seeking Alpha
Seeking Alpha
·
१ घण्टा पहिले
The 4 Effects Pumping S&P 500 And Tech/AI Earnings (NYSEARCA:SPY)
Profile
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment. Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the company is headquartered in Cambridge, Massachusetts and has locations on six continents, in over 45 countries. BeOne has a large presence in the Chinese market. BeOne Medicines has developed several medicines, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. On 14 November 2024 the company announced its intention to rebrand as BeOne Medicines. BeOne changed its stock ticker to ONC in January 2025 and redomiciled to Basel, Switzerland in May 2025. Wikipedia
About BeOne Medicines AG
CEOJohn Vincent Oyler | John Vincent Oyler
Employees१२ हजार
Founded२०१० अक्टोबर २८
Headquarters-
Sector-
Next call in 36:13:15
मे ६, बुध, ०८:००
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (०.८१ est.)USD
Revenue / Estimate
-/ (१.४४ अरब est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ मार्च
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
Revenue
१.१२ अरब
१.३२ अरब
१.४१ अरब
१.५० अरब
Cost of goods sold
१६.५० करोड
१६.४६ करोड
१९.६५ करोड
१४.२४ करोड
Cost of revenue
१६.५० करोड
१६.४६ करोड
१९.६५ करोड
१४.२४ करोड
Research and development expenses
४८.१९ करोड
५२.४९ करोड
५२.३७ करोड
६१.५४ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४५.९३ करोड
५३.७९ करोड
५२.९० करोड
५५.५३ करोड
Operating expense
९४.१२ करोड
१.०६ अरब
१.०५ अरब
१.१७ अरब
Total operating expenses
१.११ अरब
१.२३ अरब
१.२५ अरब
१.३१ अरब
Operating income
१.११ करोड
८.७९ करोड
१६.३१ करोड
१८.५० करोड
Other non operating income
१.९४ करोड
१.३२ करोड
-४७.६५ लाख
४१.५६ लाख
EBT including unusual items
२.०९ करोड
९.९५ करोड
१४.७२ करोड
१४.९२ करोड
EBT excluding unusual items
२.३० करोड
१०.२७ करोड
१६.०८ करोड
१९.०० करोड
Income tax expense
१.९६ करोड
५२.२९ लाख
२.२३ करोड
८.२७ करोड
Effective tax rate
९३.९२%
५.२५%
१५.१७%
५५.४४%
Other operating expenses
-
-
-
-
Net income
१२.७० लाख
९.४३ करोड
१२.४८ करोड
६.६५ करोड
Net profit margin
०.११%
७.१७%
८.८४%
४.४४%
Earnings per share
-
०.८४
१.०९
०.५८
Interest and investment income
१.२८ करोड
१.१५ करोड
१.३८ करोड
३.२४ करोड
Interest expense
-७०.०२ लाख
-७९.९४ लाख
-१.०८ करोड
-३.२५ करोड
Net interest expenses
५८.४८ लाख
३४.९७ लाख
३०.२९ लाख
-१.०३ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
४.२७ करोड
११.७८ करोड
१९.८९ करोड
२१.९५ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more